OpenURL Connection Search

Select item for more details and to access through your institution.

Seronegative paraneoplastic cerebellar degeneration: the PNS Euronetwork experience.
Published in:
European Journal of Neurology, 2014, v. 21, n. 5, p. 731, doi. 10.1111/ene.12368
By:
- Ducray, F.;
- Demarquay, G.;
- Graus, F.;
- Decullier, E.;
- Antoine, J. ‐ C.;
- Giometto, B.;
- Psimaras, D.;
- Delattre, J. ‐ Y.;
- Carpentier, A. F.;
- Honnorat, J.
Publication type:
Article
Dramatic improvement after rituximab in a patient with paraneoplastic treatment-refractory Morvan syndrome associated with anti- CASPR2 antibodies.
Published in:
European Journal of Neurology, 2013, v. 20, n. 7, p. e96, doi. 10.1111/ene.12164
By:
- Ong, E.;
- Viaccoz, A.;
- Ducray, F.;
- Pérol, M.;
- Cavillon, G.;
- Rogemond, V.;
- Honnorat, J.;
- Petiot, P.
Publication type:
Article
Anti- N-methyl- d-aspartate receptor encephalitis with acute disseminated encephalomyelitis-like MRI features.
Published in:
European Journal of Neurology, 2012, v. 19, n. 2, p. e16, doi. 10.1111/j.1468-1331.2011.03617.x
By:
- Lekoubou, A.;
- Viaccoz, A.;
- Didelot, A.;
- Anastasi, A.;
- Marignier, R.;
- Ducray, F.;
- Rogemond, V.;
- Honnorat, J.
Publication type:
Article
Enhancing education through community engagement: Perspectives of student volunteers.
Published in:
African Journal of Health Professions Education, 2023, v. 15, n. 3, p. 2, doi. 10.7196/AJHPE.2023.v15i3.1673
By:
- Kell, C. M.;
- Haffejee, F.;
- Ducray, J. F.
Publication type:
Article
Pituitary Tumor Centers of Excellence (PTCOE) should now include neuro-oncologic input.
Published in:
2023
By:
- Jouanneau, E.;
- Calvanese, F;
- Ducray, F;
- Raverot, G.
Publication type:
Letter
Glioblastomes: aspects moléculaires et prise en charge actuelle.
Published in:
Oncologie (Tech Science Press), 2009, v. 11, n. 2, p. 67, doi. 10.1007/s10269-008-1037-6
By:
- Ducray, F.;
- Chinot, O.
Publication type:
Article
Current trends in the management of glioblastoma in a French University Hospital and associated direct costs.
Published in:
Journal of Clinical Pharmacy & Therapeutics, 2016, v. 41, n. 1, p. 47, doi. 10.1111/jcpt.12346
By:
- Henaine, A. M.;
- Paubel, N.;
- Ducray, F.;
- Diebold, G.;
- Frappaz, D.;
- Guyotat, J.;
- Cartalat‐Carel, S.;
- Aulagner, G.;
- Hartmann, D.;
- Honnorat, J.;
- Armoiry, X.
Publication type:
Article
Management of glioblastoma: comparison of clinical practices and cost-effectiveness in two cohorts of patients (2008 versus 2004) diagnosed in a French university hospital.
Published in:
Journal of Clinical Pharmacy & Therapeutics, 2014, v. 39, n. 6, p. 642, doi. 10.1111/jcpt.12199
By:
- Diebold, G.;
- Ducray, F.;
- Henaine, A.‐M.;
- Frappaz, D.;
- Guyotat, J.;
- Cartalat‐Carel, S.;
- Breant, V.;
- Fouquet, A.;
- Aulagner, G.;
- Honnorat, J.;
- Armoiry, X.
Publication type:
Article
P14.12 Gyriform infiltration as imaging biomarker for adult diffuse astrocytic glioma, IDH wildtype, with molecular features of glioblastoma.
Published in:
Neuro-Oncology, 2021, v. 23, p. ii40, doi. 10.1093/neuonc/noab180.137
By:
- Mesny, E;
- Barritault, M;
- Izquierdo, C;
- Poncet, D;
- d'Hombres, A;
- Guyotat, J;
- Jouanneau, E;
- Ameli, R;
- Honnorat, J;
- Meyronet, D;
- Ducray, F
Publication type:
Article
KS02.4.A Olaparib in Recurrent IDH-mutant High-Grade Glioma (OLAGLI).
Published in:
2021
By:
- Ducray, F;
- Sanson, M;
- Chinot, O;
- Fontanilles, M;
- Rivoirard, R;
- Thomas-Maisonneuve, L;
- Cartalat, S;
- Tabouret, E;
- Bonneville-Levard, A;
- Darlix, A;
- Ameli, R;
- Meyronet, D;
- Gueyffier, F;
- Remontet, L;
- Maucort-Boulch, D;
- Dehais, C;
- Honnorat, J
Publication type:
Abstract
OS02.6.A The TeloDIAG: How telomeric parameters can help in glioma rapid diagnosis and liquid biopsies approaches.
Published in:
Neuro-Oncology, 2021, v. 23, p. ii5, doi. 10.1093/neuonc/noab180.015
By:
- Billard, P;
- Guerriau, C;
- Carpentier, C;
- Juillard, F;
- Grandin, N;
- Lomonte, P;
- Kantapareddy, P;
- Barritault, M;
- Rimokh, R;
- Verrelle, P;
- Maucort-Boulch, D;
- Figarella-Branger, D;
- Ducray, F;
- Dehais, C;
- Charbonneau, M;
- Meyronet, D;
- Poncet, D A
Publication type:
Article
OS02.4.A Molecular characterization of adult cerebellar glioblastomas identifies distinct prognosis subgroups.
Published in:
2021
By:
- Picart, T;
- Poncet, D;
- Barritault, M;
- Pallud, J;
- Metellus, P;
- Zouaoui, S;
- Bauchet, L;
- Guyotat, J;
- Gabut, M;
- Honnorat, J;
- Ducray, F;
- Meyronet, D
Publication type:
Abstract
P14.88 Comparison of SNaPshot PCR and digital droplet PCR for the identification of TERT promoter in non-diagnostic biopsies from glioma patients.
Published in:
Neuro-Oncology, 2019, v. 21, p. iii88, doi. 10.1093/neuonc/noz126.323
By:
- Poncet, D;
- Picart, T;
- Guyotat, J;
- Jouanneau, E;
- Joubert, B;
- Vasiljevic, A;
- Honnorat, J;
- Meyronet, D;
- Ducray, F;
- Barritault, M
Publication type:
Article
P14.76 Characteristics of anaplastic oligodendrogliomas short-term survivors: a POLA network study.
Published in:
Neuro-Oncology, 2019, v. 21, p. iii85, doi. 10.1093/neuonc/noz126.311
By:
- Garnier, L;
- Dehais, C;
- Curtit, E;
- Tabouret, E;
- Ramirez, C;
- Vauleon, E;
- Bourg, V;
- Boone, M;
- Figarella-Branger, D;
- Ducray, F
Publication type:
Article
P14.33 Adult brainstem gliomas in neurofibromatosis type 1 (NF1).
Published in:
Neuro-Oncology, 2019, v. 21, p. iii74, doi. 10.1093/neuonc/noz126.268
By:
- Guillamo, J;
- Wang, A;
- Ducray, F;
- Barbarot, S;
- Chinot, O;
- Frappaz, D;
- Bauchet, L;
- Wolkenstein, P;
- Laigle-Donadey, F
Publication type:
Article
P14.13 Incidence of pseudoprogression in high-grade IDH-mutant gliomas.
Published in:
Neuro-Oncology, 2019, v. 21, p. iii69, doi. 10.1093/neuonc/noz126.248
By:
- SEYVE, A;
- Cartalat, S;
- Meyronet, D;
- D'hombres, A;
- Barritault, M;
- Jouanneau, E;
- Berhouma, M;
- Guyotat, J;
- Honnorat, J;
- Ducray, F
Publication type:
Article
P13.02 Conventional MRI radiomics in the diagnosis of early- and pseudo-progression.
Published in:
Neuro-Oncology, 2019, v. 21, p. iii62, doi. 10.1093/neuonc/noz126.223
By:
- Sadr, A Bani;
- Eker, O F;
- Berner, L;
- Ameli, R;
- Hermier, M;
- Barritault, M;
- Meyronet, D;
- Guyotat, J;
- Jouanneau, E;
- Honnorat, J;
- Ducray, F;
- Berthezène, Y
Publication type:
Article
P04.12 Characteristics of IDH-mutant gliomas with non-canonical IDH mutations.
Published in:
Neuro-Oncology, 2019, v. 21, p. iii31, doi. 10.1093/neuonc/noz126.107
By:
- Poetsch, L;
- Dehais, C;
- Frénel, J;
- Siegfried, A;
- Lacomme, S;
- Seizeur, R;
- Larrieu-Ciron, D;
- Cappellen, D;
- Loussouarn, D;
- Ferec, C;
- Eimer, S;
- Carpentier, C;
- Sanson, M;
- Delattre, J;
- Figarella-Branger, D;
- Ducray, F;
- network, POLA;
- Bronnimann, C
Publication type:
Article
P04.18 Management of diffuse gliomas using hypnosis-aided awake surgery: oncological and functional preliminary results in a series of 16 cases.
Published in:
Neuro-Oncology, 2019, v. 21, p. iii33, doi. 10.1093/neuonc/noz126.113
By:
- Picart, T;
- Bracho, G Pardey;
- Ameli, R;
- Berner, L;
- Thomas, L;
- Cartalat, S;
- Honnorat, J;
- Ducray, F;
- Guyotat, J
Publication type:
Article
OS9.3 Clinical, molecular and radiomic profile of gliomas with FGFR3-TACC3 fusion.
Published in:
Neuro-Oncology, 2019, v. 21, p. iii18, doi. 10.1093/neuonc/noz126.061
By:
- Picca, A;
- Alentorn, A;
- Saragoussi, E;
- Bielle, F;
- Ducray, F;
- Villa, C;
- Schmitt, Y;
- Lerond, J;
- Leclerc, J;
- Lasorella, A;
- Iavarone, A;
- Mokhtari, K;
- Savatovsky, J;
- Sanson, M;
- Stefano, A Di
Publication type:
Article
OS9.2 Radiomics analysis of lower-grade gliomas, a POLA Network study.
Published in:
Neuro-Oncology, 2019, v. 21, p. iii18, doi. 10.1093/neuonc/noz126.060
By:
- Younan, N;
- Douzane, H;
- Duran-Pena, A;
- Nichelli, L;
- Garcilazo, Y;
- Dehais, C;
- Ducray, F;
- Carpentier, C;
- Mokhtari, K;
- Figarella-Branger, D;
- Delattre, J;
- Idbaih, A;
- Alentorn, A
Publication type:
Article
OS8.4 Impact of brain invasion assessment on outcome in intracranial grade II meningiomas.
Published in:
Neuro-Oncology, 2019, v. 21, p. iii16, doi. 10.1093/neuonc/noz126.054
By:
- Picart, T;
- Dumot, C;
- Ducray, F;
- Durand, A;
- Guyotat, J;
- Berhouma, M;
- Meyronet, D
Publication type:
Article
OS5.5 Characteristics of high-grade gliomas with H3 G34 mutation in adults.
Published in:
Neuro-Oncology, 2019, v. 21, p. iii12, doi. 10.1093/neuonc/noz126.038
By:
- Picart, T;
- Barritault, M;
- Tabouret, E;
- Idbaih, A;
- Gracia, C Izquierdo;
- Poncet, D;
- Honnorat, J;
- Meyronet, D;
- Guyotat, J;
- Ducray, F
Publication type:
Article
OS5.4 Characteristics of adult diffuse H3K27M-mutant gliomas at recurrence.
Published in:
Neuro-Oncology, 2019, v. 21, p. iii11, doi. 10.1093/neuonc/noz126.037
By:
- Hodroj, K;
- Meyronet, D;
- Barritault, M;
- Bourg, V;
- Cohen-Moyal, E;
- Cartalat, S;
- Ameli, R;
- Berhouma, M;
- Honnorat, J;
- Ducray, F
Publication type:
Article
JS1.2 Increased frequency of paraneoplastic encephalitis with anti-Ma2 antibodies in the cancer immunotherapy era.
Published in:
Neuro-Oncology, 2019, v. 21, p. iii4, doi. 10.1093/neuonc/noz126.011
By:
- Vogrig, A;
- Fouret, M;
- Joubert, B;
- Picard, G;
- Rogemond, V;
- Pinto, A;
- Castrillo, S Muñiz;
- Roger, M;
- Raimbourg, J;
- Dayen, C;
- Grignou, L;
- Pallix-Guyot, M;
- Lannoy, J;
- Ducray, F;
- Desestret, V;
- Psimaras, D;
- Honnorat, J
Publication type:
Article
PL1.1 CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDHmutant gliomas.
Published in:
Neuro-Oncology, 2019, v. 21, p. iii1, doi. 10.1093/neuonc/noz126.000
By:
- Appay, R;
- Dehais, C;
- Colin, C;
- Alentorn, A;
- Carpentier, C;
- Ducray, F;
- Ibdaih, A;
- Kamoun, A;
- Mokhtari, K;
- Tabouret, E;
- Uro-Coste, E;
- Delattre, J;
- Figarella-Branger, D
Publication type:
Article
P01.148 Intra-tumor heterogeneity analysis of low-grade gliomas. A POLA Network study.
Published in:
Neuro-Oncology, 2018, v. 20, p. iii266, doi. 10.1093/neuonc/noy139.190
By:
- Alentorn, A;
- Labreche, K;
- Dehais, C;
- Carpentier, C;
- Ducray, F;
- Mokhtari, K;
- Figarella-Branger, D;
- Sanson, M;
- Delattre, J;
- Idbaih, A
Publication type:
Article
The cost-effectiveness of tumor-treating fields therapy in patients with newly diagnosed glioblastoma.
Published in:
Neuro-Oncology, 2016, v. 18, n. 8, p. 1129, doi. 10.1093/neuonc/now102
By:
- Bernard-Arnoux, F.;
- Lamure, M.;
- Ducray, F.;
- Aulagner, G.;
- Honnorat, J.;
- Armoiry, X.
Publication type:
Article
O10.02 MITOTIC INDEX, MICROVASCULAR PROLIFERATION AND NECROSIS DEFINE THREE GROUPS OF 1P/19Q CO-DELETED ANAPLASTIC OLIGODENDROGLIOMAS ASSOCIATED WITH DIFFERENT GENOMIC ALTERATIONS.
Published in:
Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii23, doi. 10.1093/neuonc/nou174.83
By:
- Figarella-Branger, D.;
- Mokhtari, K.;
- Dehais, C.;
- Jouvet, A.;
- Uro-Coste, E.;
- Colin, C.;
- Carpentier, C.;
- Ducray, F.;
- Idbaih, A.;
- Network, French POLA
Publication type:
Article
O3.03 THE SPECTRUM OF LATE PAROXYSMAL NEUROLOGICAL SYNDROMES AFTER BRAIN IRRADIATION.
Published in:
Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii5, doi. 10.1093/neuonc/nou174.17
By:
- Berzero, G.;
- Group, Pavia Neuro-oncology;
- Ducray, F.;
- Giometto, B.;
- Silvani, A.;
- Salmaggi, A.;
- Eoli, M.;
- Finocchiaro, G.;
- Vidiri, A.;
- Pace, A.
Publication type:
Article
P17.01 CHROMOSOME ARM 9P LOSS OF HETEROZYGOSITY IS A MARKER OF SHORTER SURVIVAL IN 1P/19Q CO-DELETED ANAPLASTIC OLIGODENDROGLIOMA. A POLA NETWORK STUDY.
Published in:
Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii86, doi. 10.1093/neuonc/nou174.331
By:
- Alentorn, A.;
- Dehais, C.;
- Carpentier, C.;
- Mokhtari, K.;
- Ducray, F.;
- Figarella-Branger, D.;
- Delattre, J.;
- Idbaih, A.;
- (POLA)”, POLA Network “Prise en charge des OLigodendrogliomes Anaplasiques
Publication type:
Article
O8.08 CIC MUTATION IS A POOR PROGNOSIS FACTOR IN 1P19Q CODELETED GLIOMAS, ASSOCIATED TO AN UP-REGULATION OF PROLIFERATION PATHWAYS.
Published in:
Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii19, doi. 10.1093/neuonc/nou174.69
By:
- Gleize, V.;
- Alentorn, A.;
- Connen de Kérillis, L.;
- Labussière, M.;
- Mangesius, S.;
- Ducray, F.;
- Mokhtari, K.;
- Villa, C.;
- Sanson, M.
Publication type:
Article
Increased rCBV in status epilepticus.
Published in:
2012
By:
- Rath, J.;
- Smits, M.;
- Ducray, F.;
- Bent, M.
Publication type:
Letter
Prediction of Response to Temozolomide in Low-Grade Glioma Patients Based on Tumor Size Dynamics and Genetic Characteristics.
Published in:
CPT: Pharmacometrics & Systems Pharmacology, 2015, v. 4, n. 12, p. 728, doi. 10.1002/psp4.54
By:
- Mazzocco, P;
- Barthélémy, C;
- Kaloshi, G;
- Lavielle, M;
- Ricard, D;
- Idbaih, A;
- Psimaras, D;
- Renard, M‐A;
- Alentorn, A;
- Honnorat, J;
- Delattre, J‐Y;
- Ducray, F;
- Ribba, B
Publication type:
Article
Advanced multiparametric magnetic resonance imaging of multinodular and vacuolating neuronal tumor.
Published in:
European Journal of Neurology, 2020, v. 27, n. 8, p. 1561, doi. 10.1111/ene.14264
By:
- Lecler, A.;
- Broquet, V.;
- Bailleux, J.;
- Carsin, B.;
- Adle‐Biassette, H.;
- Baloglu, S.;
- Forestier, G.;
- Bonneville, F.;
- Calvier, E.;
- Chauvet, D.;
- Comby, P. O.;
- Cottier, J. P.;
- Cotton, F.;
- Deschamps, R.;
- Diard‐Detoeuf, C.;
- Ducray, F.;
- Drissi, C.;
- Elmaleh, M.;
- Farras, J.;
- Aguilar Garcia, J.
Publication type:
Article
Stroke‐like events after brain radiotherapy: a large series with long‐term follow‐up.
Published in:
European Journal of Neurology, 2019, v. 26, n. 4, p. 639, doi. 10.1111/ene.13870
By:
- Di Stefano, A. L.;
- Berzero, G.;
- Ducray, F.;
- Eoli, M.;
- Pichiecchio, A.;
- Farina, L. M.;
- Cuccarini, V.;
- Brunelli, M. C.;
- Diamanti, L.;
- Condette Auliac, S.;
- Salmaggi, A.;
- Silvani, A.;
- Giometto, B.;
- Pace, A.;
- Vidiri, A.;
- Bourdain, F.;
- Bastianello, S.;
- Ceroni, M.;
- Marchioni, E.
Publication type:
Article
Cervical cancer knowledge and screening uptake by marginalized population of women in inner-city Durban, South Africa: Insights into the need for increased health literacy.
Published in:
Women's Health (17455057), 2021, p. 1, doi. 10.1177/17455065211047141
By:
- Ducray, Jennifer F;
- Kell, Colette M;
- Basdav, Jyotika;
- Haffejee, Firoza
Publication type:
Article
Cervical cancer knowledge and screening uptake by marginalized population of women in inner-city Durban, South Africa: Insights into the need for increased health literacy.
Published in:
Women's Health (17455057), 2021, p. 1, doi. 10.1177/17455065211047141
By:
- Ducray, Jennifer F;
- Kell, Colette M;
- Basdav, Jyotika;
- Haffejee, Firoza
Publication type:
Article
Alpha-internexin expression predicts outcome in anaplastic oligodendroglial tumors and may positively impact the efficacy of chemotherapy: European organization for research and treatment of cancer trial 26951.
Published in:
2011
By:
- Mokhtari K;
- Ducray F;
- Kros JM;
- Gorlia T;
- Idbaih A;
- Taphoorn M;
- Wesseling P;
- Hoang-Xuan K;
- Van den Bent M;
- Sanson M
Publication type:
Journal Article
Characteristics of IDH-mutant gliomas with non-canonical IDH mutation.
Published in:
Journal of Neuro-Oncology, 2021, v. 151, n. 2, p. 279, doi. 10.1007/s11060-020-03662-x
By:
- Poetsch, L.;
- Bronnimann, C.;
- Loiseau, H.;
- Frénel, J. S.;
- Siegfried, A.;
- Seizeur, R.;
- Gauchotte, G.;
- Cappellen, D.;
- Carpentier, C.;
- Figarella-Branger, D.;
- Eimer, S.;
- Meyronet, D.;
- Ducray, F.;
- POLA network;
- Desenclos, C.;
- Sevestre, H;
- Menei, P;
- Rousseau, A;
- Cruel, T;
- Lopez, S
Publication type:
Article
Long-term impact of temozolomide on 1p/19q-codeleted low-grade glioma growth kinetics.
Published in:
Journal of Neuro-Oncology, 2018, v. 136, n. 3, p. 533, doi. 10.1007/s11060-017-2677-4
By:
- Izquierdo, C.;
- Alentorn, A.;
- Idbaih, A.;
- Simó, M.;
- Kaloshi, G.;
- Ricard, D.;
- Barritault, M.;
- Meyronet, D.;
- Bruna, J.;
- Honnorat, J.;
- Delattre, J. Y.;
- Ducray, F.
Publication type:
Article
Ongoing and prolonged response in adult low-grade gliomas treated with radiotherapy.
Published in:
Journal of Neuro-Oncology, 2013, v. 115, n. 2, p. 261, doi. 10.1007/s11060-013-1224-1
By:
- Ducray, F.;
- Kaloshi, G.;
- Houillier, C.;
- Idbaih, A.;
- Ribba, B.;
- Psimaras, D.;
- Marie, Y.;
- Boisselier, B.;
- Alentorn, A.;
- Dainese, L.;
- Navarro, S.;
- Mokhtari, K.;
- Sanson, M.;
- Hoang-Xuan, K.;
- Delattre, Jean-Yves
Publication type:
Article
A.6 INDIGO: a global, randomized, double-blinded, Phase 3 study of vorasidenib versus placebo in patients with grade 2 glioma with an IDH1/2 mutation (mIDH1/2).
Published in:
2024
By:
- Perry, JR;
- Mellinghoff, IK;
- van den Bent, M;
- Blumenthal, DT;
- Touat, M;
- Peters, KB;
- Clarke, J;
- Mendez, J;
- Yust-Katz, S;
- Mason, W;
- Ducray, F;
- Umemura, Y;
- Nabors, B;
- Holdhoff, M;
- Hottinger, AF;
- Arakawa, Y;
- Sepúlveda, J;
- Wick, W;
- Soffietti, R;
- Giglio, P
Publication type:
Abstract

Found: 43